Pathophysiology of focal segmental glomerulosclerosis

被引：60

作者：

Reidy, Kimberly

Kaskel, Frederick J.

机构：

[1] Childrens Hosp Montefiore, Div Pediat Nephrol, Bronx, NY 10467 USA

[2] Albert Einstein Coll Med, Childrens Hosp Montefiore, Bronx, NY 10467 USA

来源：

PEDIATRIC NEPHROLOGY | 2007年 / 22卷 / 03期

关键词：

focal segmental glomerulosclerosis (FSGS); nephrotic syndrome; pathophysiology; podocyte; injury; animal models; nephrin; podocin; transforming growth factor (TGF beta); tubulointerstitial;

D O I：

10.1007/s00467-006-0357-2

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Focal segmental glomerulosclerosis (FSGS) is a major cause of idiopathic steroid-resistant nephrotic syndrome (SRNS) and end-stage kidney disease (ESKD). In recent years, animal models and studies of familial forms of nephrotic syndrome helped elucidate some mechanisms of podocyte injury and disease progression in FSGS. This article reviews some of the experimental and clinical data on the pathophysiology of FSGS.

引用

收藏

页码：350 / 354

页数：5

相关论文

共 30 条

[1] The role of podocytes in glomerular pathobiology [J].

Katsuhiko Asanuma ;

Peter Mundel .

Journal of Clinical and Experimental Nephrology, 2003, 7 (4) :255-259

[2]

Barisoni L, 1999, J AM SOC NEPHROL, V10, P51

[3] Pathologic classification of focal segmental glomerulosclerosis [J].

D'Agati, V .

SEMINARS IN NEPHROLOGY, 2003, 23 (02) :117-134

[4] Focal and segmental glomerulosclerosis: Varying biologic mechanisms underlie a final histopathologic end point [J].

Daskalakis, N ;

Winn, MP .

SEMINARS IN NEPHROLOGY, 2006, 26 (02) :89-94

[5] The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis [J].

Dijkman, H ;

Smeets, B ;

van der Laak, J ;

Steenbergen, E ;

Wetzels, J .

KIDNEY INTERNATIONAL, 2005, 68 (04) :1562-1572

[6] Focal and segmental glomerulosclerosis and plasma cell proliferative disorders [J].

Dingli, D ;

Larson, DR ;

Plevak, MF ;

Grande, JP ;

Kyle, RA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (02) :278-282

[7] Is there really an increase in non-minimal change nephrotic syndrome in children? [J].

Filler, G ;

Young, E ;

Geier, P ;

Carpenter, B ;

Drukker, A ;

Feber, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1107-1113

[8] Animal models of FSGS: Lessons for pathogenesis and treatment [J].

Fogo, AB .

SEMINARS IN NEPHROLOGY, 2003, 23 (02) :161-171

[9] Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor [J].

Ghiggeri, GM ;

Artero, M ;

Carraro, M ;

Perfumo, F .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) :882-885

[10] Toward a unified theory of renal progression [J].

Harris, RC ;

Neilson, EG .

ANNUAL REVIEW OF MEDICINE, 2006, 57 :365-380